Grażyna Rydzewska

ORCID: 0000-0002-1267-7620
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Inflammatory Bowel Disease
  • Pancreatitis Pathology and Treatment
  • Microscopic Colitis
  • Pancreatic and Hepatic Oncology Research
  • Gastrointestinal motility and disorders
  • Neuroendocrine Tumor Research Advances
  • Helicobacter pylori-related gastroenterology studies
  • Gastrointestinal disorders and treatments
  • Diverticular Disease and Complications
  • Eosinophilic Esophagitis
  • COVID-19 Clinical Research Studies
  • Biosimilars and Bioanalytical Methods
  • Digestive system and related health
  • SARS-CoV-2 and COVID-19 Research
  • Clostridium difficile and Clostridium perfringens research
  • Lung Cancer Research Studies
  • Celiac Disease Research and Management
  • Pancreatic function and diabetes
  • Gastroesophageal reflux and treatments
  • Autoimmune and Inflammatory Disorders
  • Colorectal Cancer Screening and Detection
  • Diet and metabolism studies
  • Gastric Cancer Management and Outcomes
  • Liver Disease Diagnosis and Treatment
  • Pharmaceutical studies and practices

Jan Kochanowski University
2016-2025

Central Clinical Hospital
2016-2025

Ministry of Interior and Administration
2012-2025

Ministry of Internal Affairs of the Republic of Tajikistan
2025

University of California, San Diego
2023

Centralny Szpital Kliniczny
2004-2021

Collegium Medicum in Bydgoszcz
2013-2020

Ministry of Interior
2018

Kielce University of Technology
2017

Medical University of Silesia
2014

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Eder P, Łodyga M, Gawron-Kiszka et al. Guidelines for the management of ulcerative colitis. Recommendations Polish Society Gastroenterology and National Consultant in Gastroenterology. Review/Przegląd Gastroenterologiczny. 2023;18(1):1-42. doi:10.5114/pg.2023.125882. APA Eder, P., Łodyga, M., Gawron-Kiszka, Dobrowolska, A., Gonciarz, & Hartleb, M. (2023). Gastroenterologiczny, 18(1), 1-42....

10.5114/pg.2023.125882 article EN cc-by-nc-sa Gastroenterology Review 2023-01-01

Abstract Background Microscopic colitis (MC) is a chronic inflammatory bowel disease (IBD), characterized by watery diarrhea without blood, fecal urgency and distninct histological features. Symptoms of MC resemble those irritable syndrome (IBS), which can delay accurate diagnosis effective treatment. The potential overlap in symptoms may impede to select management strategies. Methods purpose establishing the Polish Registry Colitis was understand clinical characteristics patients improve...

10.1093/ecco-jcc/jjae190.0505 article EN Journal of Crohn s and Colitis 2025-01-01

W ostatnim czasie obserwuje się większe zainteresowanie rzadkimi nowotworami neuroendokrynnymi żołądkowo-jelitowo-trzustkowymi (GEP NEN). Wykrywalność nowotworów neuroendokrynnych w ostatnich latach wzrosła. Ponad 50% GEP NEN stanowią rakowiaki, które najczęściej są znajdowane przypadkowo podczas zabiegu operacyjnego jelicie cienkim i wyrostku robaczkowym oraz momencie rozpoznania przerzutów odległych, głównie do wątroby. Istnieje konieczność współdziałania specjalistów różnych dziedzin...

10.5603/ep.2013.0028 article PL Endokrynologia Polska 2014-01-03

Toll-like receptors [TLRs] are potential drug targets for immunomodulation. We determined the safety and efficacy of TLR-9 agonist DNA-based immunomodulatory sequence 0150 [DIMS0150] in ulcerative colitis [UC] patients refractory to standard therapy.In this randomized, double-blind, placebo-controlled trial, 131 with moderate-to-severe active UC were randomized receive two single doses oligonucleotide DIMS0150 [30 mg] or placebo administered topically during lower GI endoscopy at baseline...

10.1093/ecco-jcc/jjw103 article EN cc-by Journal of Crohn s and Colitis 2016-05-20

ARTICLE Clostridioides difficile infection in COVID -19 121 transcription-polymerase chain reaction test.The treatment of is mainly symptomatic and based on international research guidelines. 7,8Recommended drugs include chloroquine, hydroxychloroquine, azithromycin, lopinavir / ritonavir. 9The use tocilizumab remdesivir can be considered severely ill patients. 10,11As the rates bacterial coinfections are high, empiric antibiotic therapy often necessary. 7It has been estimated that over...

10.20452/pamw.15715 article EN Polskie Archiwum Medycyny Wewnętrznej 2020-12-14

Continuous progress in the diagnostics and treatment of neuroendocrine neoplasms (NENs), emerging results new clinical trials, guidelines issued by medical societies have prompted experts from Polish Network Neuroendocrine Tumours to update 2017 recommendations regarding management neoplasms. This article presents general for NENs, resulting findings participating Fourth Round Table Conference, entitled "Polish Guidelines Diagnostics Treatment Neoplasms gastrointestinal tract, Żelechów, June...

10.5603/ep.a2022.0049 article EN cc-by-nc-nd Endokrynologia Polska 2022-06-30

A randomized controlled trial was conducted to clarify whether continuous regional arterial infusion (CRAI) of protease inhibitor and antibiotic could reduce mortality rate severe acute pancreatitis (SAP).Seventy-eight patients with SAP were included in the study. Thirty-nine treated CRAI, 31 completed study; another group 39 without CRAI therapy. Groups well matched clinical characteristics. The continuously nafamostat mesylate 240 mg/d imipenem 1 g/d for 5 days via one arteries perfusing...

10.1097/mpa.0b013e3181d37239 article EN Pancreas 2010-04-27

Exclusive enteral nutrition (EEN) is a first-line treatment in active, mild to moderate Crohn’s disease (CD) children. The exclusion diet (CDED), which avoids products known have pro-inflammatory effect on the intestinal mucosa, presents similar effectiveness EEN for inducing remission paediatric population. aim of study was evaluate CDED adult patients. Between March 2020 and May 2021, 32 patients gastroenterology outpatient centre were treated according assumptions CDED. seen at baseline,...

10.3390/nu13114112 article EN Nutrients 2021-11-17

ObjectiveThis study aimed to investigate the efficacy and safety of convalescent plasma (CP) transfusion in a group high-risk COVID-19 patients.MethodsThis prospective included 204 patients from single tertiary-care hospital, hospitalized with COVID-19, whom 102 were treated CP administration standard care (PG) others who received only (CG). The CG was selected 336 using propensity-score matching (PSM) technique age, MEWS score, comorbidities. primary outcome mortality rate; secondary...

10.1016/j.ijid.2021.02.054 article EN cc-by-nc-nd International Journal of Infectious Diseases 2021-02-17

This paper is an update of the diagnostic and therapeutic recommendations National Consultant for Gastroenterology Polish Society from 2012. It contains 46 diagnosis treatment, both pharmacological surgical, Crohn's disease in adults. The guidelines were developed by a group experts appointed field Gastroenterology. methodology related to GRADE was used assess quality strength available recommendations. degree expert support proposed statement, assessment evidence recommendation assessed on...

10.5114/pg.2021.110914 article EN cc-by-nc-sa Gastroenterology Review 2021-01-01

Introduction: There are many known risk factors for osteoporosis (OST) among patients with inflammatory bowel disease (IBD), one of which is physical activity. Material and methods: The aim the study to assess frequency OST 232 IBD compared a group 199 without IBD. participants underwent dual-energy X-ray absorptiometry, laboratory tests, completed questionnaire about their Results: It was found that 7.3% suffered from OST. Male gender, ulcerative colitis, extensive inflammation in...

10.3390/nu15051151 article EN Nutrients 2023-02-24

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Pietrzak A, Skrzydło-Radomańska B, Mulak et al. Guidelines on the management of irritable bowel syndrome. Gastroenterology Review/Przegląd Gastroenterologiczny. 2018;13(4):259-288. doi:10.5114/pg.2018.78343. APA Pietrzak, A., Skrzydło-Radomańska, B., Mulak, Lipiński, M., Małecka-Panas, E., & Reguła, J. (2018). Gastroenterologiczny, 13(4), 259-288. https://doi.org/10.5114/pg.2018.78343 Chicago Anna, Barbara...

10.5114/pg.2018.78343 article EN Gastroenterology Review 2018-01-01

Abstract Background Intestinal strictures are a common and serious complication of inflammatory bowel disease (IBD). Endoscopic balloon dilatation (EBD) is the first step treatment to avoid surgery. Methods The aim this study was assess prevalence, risk factors clinical sequelae difficult EBD. In retrospective, multi-center study, 861 IBD patients treated with EBD due were included. We evaluated for EBD, defined as ≥3 per year. Results During 23.00 (14.00;42.00) months median follow-up there...

10.1093/ecco-jcc/jjae190.1047 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background Crohn's disease (CD) is a chronic inflammatory bowel disorder with debilitating complications such as perianal fistulas, affecting 14-38% of patients (1). Conventional treatments often achieve limited success, necessitating adjunctive approaches (2,3). Hyperbaric Oxygen Therapy (HBOT), known for its wound-healing and anti-inflammatory properties, has emerged potential therapy complex CD cases (4,5). This study evaluates the efficacy HBOT in combination standard reducing...

10.1093/ecco-jcc/jjae190.0954 article EN Journal of Crohn s and Colitis 2025-01-01

Abstract Background Data regarding on CIN (cervical intraepithelial neoplasia) in IBD are conflicting, however it is considered that women with inflammatory bowel disease (IBD) may be at higher risk for CIN, especially immunocompromised individuals. The aim of this study was to assess the prevalence abnormal cervix cytology patients. Methods Retrospectively we have analysed digital data patients what more receiving immunosuppressive, small molecules or/and biological treatment. Results from...

10.1093/ecco-jcc/jjae190.0804 article EN Journal of Crohn s and Colitis 2025-01-01

Background: Upadacitinib (UPA) is a new oral selective Janus Kinase (JAK) inhibitor that has shown high efficacy in the treatment of ulcerative colitis (UC). We present data from multicenter real-world study. Methods: To assess UPA, Total Mayo Score (TMS), fecal calprotectin (FC), endoscopy, and intestinal ultrasonography (IUS) were performed. Results: The study population included 76 patients. An amount 26.3% patients biologics small molecules-naive, while 73.7% exposed. By Week 8, 93.4%...

10.3390/jcm14051695 article EN Journal of Clinical Medicine 2025-03-03

Intestinal strictures are a common and serious complication of inflammatory bowel disease (IBD). Endoscopic balloon dilatation (EBD) is the first step treatment to avoid surgery. The aim this study was assess prevalence, risk factors clinical sequelae difficult EBD. In retrospective, multi-center study, 861 IBD patients treated with EBD due were included. We evaluated for EBD, defined as ≥3 per year. During 23.00 (14.00;42.00) months median follow-up there 392 (45.5%) easier performed, while...

10.1016/j.gie.2025.02.036 article EN cc-by Gastrointestinal Endoscopy 2025-03-01
Coming Soon ...